CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis

Background: Disease activity in the first years after a diagnosis of relapsing-remitting multiple sclerosis (RRMS) is a negative prognostic factor for long-term disability. Markers of both clinical and radiological responses to disease-modifying therapies (DMTs) are advocated. Objective: The objecti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Therapeutic advances in neurological disorders Jg. 15; S. 17562864221092124
Hauptverfasser:	Marastoni, Damiano, Pisani, Anna I., Schiavi, Gianmarco, Mazziotti, Valentina, Castellaro, Marco, Tamanti, Agnese, Bosello, Francesca, Crescenzo, Francesco, Ricciardi, Giuseppe K., Montemezzi, Stefania, Pizzini, Francesca B., Calabrese, Massimiliano
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London, England SAGE Publications 2022 SAGE PUBLICATIONS, INC SAGE Publishing
Schlagworte:	APRIL protein CD163 antigen Cerebrospinal fluid Chemokines CXCL12 protein CXCL13 protein Demography Diagnosis Inflammation Interleukin 12 Ligands Lymphocytes B Magnetic resonance imaging Multiple sclerosis Original Research Osteopontin Patients Substantia alba Substantia grisea Tumor necrosis factor Tumor necrosis factor-TNF Tumors γ-Interferon relapsing multiple sclerosis osteopontin disease activity cytokines dimethyl fumarate chemokines TNF
ISSN:	1756-2864, 1756-2856, 1756-2864
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!